The core activity of Scailyte is the development and application of digital solutions for single-cell analysis, particularly in the field of cell therapy. The company focuses on the development of biomarkers and the application of artificial intelligence and machine learning in single-cell biology. Scailyte provides solutions for the pharmaceutical, biotech, and clinical research industries and develops products such as ScaiVision, a system for single-cell analysis.